A huge amount of data strongly imply the involvement of transcription factor NF-κB in the onset and progression of a variety of tumors, highlighting its important role in modulating therapeutic efficacy, in particular on multidrug resistance cancers. The gene discussed is NFKB1; the disease is cancer.